GMA Solutions was founded by Mark Connolly.  Mark has extensive local and global pricing and reimbursement experience gained while working in Australia, Switzerland, the United Kingdom and the United States. Mark holds postgraduate qualifications in Health Economics from Curtin University in Australia and in Pharmacology from the University of Michigan. Mark has performed a range of economic evaluations to support pricing and product launches and evaluated the effects of pharmaceutical policy changes. 

Mark's professional experience includes working for Covance Australia, Aventis Pharma in Australia, GlaxoSmithKline in London and most recently establishing the global pricing and market access function for Ferring Pharmaceuticals in Switzerland.